Xeris Biopharma Holdings, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $159.2M
Liabilities Breakdown FY2020
Total Liabilities: $125.4M
Asset Breakdown
Total Assets: $159.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $37.6M | 23.6% |
| Accounts Receivable | $6.9M | 4.3% |
| Inventory | $8.4M | 5.2% |
| Property, Plant & Equipment | $6.7M | 4.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $99.6M | 62.6% |
Liabilities Breakdown
Total Liabilities: $125.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.1M | 2.5% |
| Long-Term Debt | $87.0M | 69.4% |
| Other Liabilities | $35.3M | 28.1% |